Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Subject: Schizophrenia - PUBLISHED VIA Brazilian Journal of Medical and Biological Research
Author(s): View Source >>
Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS
Published via Translational Psychiatry
Published via European Neuropsychopharmacology
Published via Neuropsychopharmacology
Published via Drug Testing and Analysis
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
Published via Current Pharmaceutical Design